Safilo Group SpASAFLF 62 Return-on-Tangible-Equity is 5.63% as of Dec. 2025. GuruFocus rates SAFLF with a GF Score™ of 62/100 and a GF Value™ of $1.18 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 758 Medical Devices & Instruments companies, Safilo Group SpA ranks better than 83.11% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Safilo Group SpA's annualized net income for the quarter that ended in Dec. 2025 was $16 Mil. Safilo Group SpA's average shareholder tangible equity for the quarter that ended in Dec. 2025 was $288 Mil. Therefore, Safilo Group SpA's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 5.63%.
The historical rank and industry rank for Safilo Group SpA's Return-on-Tangible-Equity or its related term are showing as below:
SAFLF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -100.29 Med: -10.46 Max: 35.37
Current: 19.78
During the past 13 years, Safilo Group SpA's highest Return-on-Tangible-Equity was 35.37%. The lowest was -100.29%. And the median was -10.46%.
SAFLF's Return-on-Tangible-Equity is ranked better than 83.11% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.08
vs SAFLF: 19.78
Safilo Group SpA (OTCPK:SAFLF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Safilo Group SpA Return-on-Tangible-Equity Related Terms
Safilo Group SpA Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Safilo Group SpA's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAFLF vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Safilo Group SpA's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Safilo Group SpA Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Safilo Group SpA's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Safilo Group SpA's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 5.63% mean?
Safilo Group SpA (SAFLF) has a Return-on-Tangible-Equity of 5.63% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Safilo Group SpA and its competitors. According to the industry distribution chart, Safilo Group SpA ranks #128 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 16.9%.
Is Safilo Group SpA's Return-on-Tangible-Equity too high?
Safilo Group SpA's current Return-on-Tangible-Equity is 5.63%. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.08. Safilo Group SpA's value of 5.63% is 38% above this industry median. Based on the distribution chart, Safilo Group SpA ranks #128 out of 758 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Safilo Group SpA has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Safilo Group SpA's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Safilo Group SpA ranks #128 out of 758 companies for Return-on-Tangible-Equity. This places Safilo Group SpA in the top 17% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.08. Safilo Group SpA's value of 5.63% is 38% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.08, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Safilo Group SpA's current Return-on-Tangible-Equity of 5.63% is 38% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Safilo Group SpA and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Safilo Group SpA's current Return-on-Tangible-Equity is 5.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Safilo Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Safilo Group SpA (SAFLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.18, compared to a current price of $2.01 — trading 70.3% above its estimated fair value. The current Return-on-Tangible-Equity is 5.63% and 38% above the Medical Devices & Instruments industry median of 4.08. Safilo Group SpA's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Safilo Group SpA (SAFLF), the current Return-on-Tangible-Equity is 5.63% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Safilo Group SpA (SAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Safilo Group SpA stock appears to be overvalued.
The current stock price of $2.01 is trading 70.3% above its estimated GF Value™ of $1.18.
GuruFocus considers Safilo Group SpA to be Significantly Overvalued.
Key valuation signals for SAFLF:
Return-on-Tangible-Equity: 5.63%
GF Value™: $1.18 vs. price of $2.01 (70.3% above fair value)
Industry Position: 38% above the Medical Devices & Instruments median (#128 of 758)
No single metric tells the full story. See the SAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Safilo Group SpA makes sunglasses and prescription eyewear. It is engaged in design, production, and wholesale distribution of its products through a network of independent distributors and commercial subsidiaries. Its products are sold through the Carrera, Smith, Polaroid and Oxydo brands, as well as a range of other licensed brands. The company operates solely through the wholesale segment channels and divides itself into the following four geographical segments: Europe, America, and Asia. The company earns the majority of its revenue from the Europe business segment.
62GF Score
Get the complete analysis for SAFLF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAFLF has been successfully added to your 
